Skip to main content

and
  1. No Access

    Article

    The value of gadobenate dimeglumine–enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure in HCC patients

    To determine the value of gadobenate dimeglumine–enhanced biliary imaging from the hepatobiliary phase for predicting post-hepatectomy liver failure (PHLF) in patients with hepatocellular carcinoma (HCC).

    Dongxiao Meng, Changhu Liang, Yuanwen Zheng, **ming Wang, Keke Liu in European Radiology (2022)

  2. No Access

    Article

    Gd-BOPTA-enhanced hepatobiliary phase MR imaging can predict the prognosis of patients with acute-on-chronic liver failure

    To determine the value of gadobenate dimeglumine (Gd-BOPTA)–enhanced magnetic resonance imaging (MRI) from the hepatobiliary phase for predicting poor outcome in acute-on-chronic liver failure (ACLF) patients.

    Chenxi Liu, Zijian Shen, Hui Ma, Xueqi Wang, **nyu Wang, Keke Liu in European Radiology (2022)

  3. No Access

    Article

    Gadobenate dimeglumine–enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis

    To determine the value of gadobenate dimeglumine (Gd-BOPTA)–enhanced biliary imaging from the hepatobiliary phase in predicting hepatic decompensation and insufficiency for patients with cirrhosis.

    Chenxi Liu, Yan Sun, Yao Yang, Yuemin Feng, **aoyu **e, Lingyu Qi in European Radiology (2021)